Mesenchymal stromal cell-derived exosomes protect against abdominal aortic aneurysm formation through CD74 modulation

Jiamin Xu1, Jiling Zhao2, Haiting Chen3

  • 1Department of Cardiology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China.

PubMed
Abstract

Insights

Mesenchymal stromal cell-derived exosomes (MSC-Exo) show therapeutic potential for abdominal aortic aneurysm (AAA). MSC-Exo promote M2 macrophage polarization, inhibiting AAA progression by modulating the CD74/TSC2-mTOR-AKT pathway.

Area of Science:

  • Cardiovascular Research
  • Regenerative Medicine
  • Immunology

Background:

  • Abdominal aortic aneurysm (AAA) pathogenesis involves macrophage polarization.
  • Mesenchymal stromal cell-derived exosomes (MSC-Exo) regulate macrophage polarization.
  • Therapeutic potential of MSC-Exo for AAA is largely unexplored.

Purpose of the Study:

  • Investigate the functional and mechanistic aspects of MSC-Exo in AAA progression.
  • Evaluate the therapeutic efficacy of MSC-Exo in AAA models.
  • Elucidate the molecular mechanisms underlying MSC-Exo's effects on macrophage polarization in AAA.

Main Methods:

  • Characterization of MSC-Exo (TEM, NTA, Western blotting).
  • Establishment of mouse AAA models (Ang II or CaCl2 induced).
  • Assessment of macrophage polarization (immunofluorescence, WB) and mechanistic analysis (4D Label-free Proteomics).

Main Results:

  • Intravenous MSC-Exo administration induced M2 macrophage polarization.
  • MSC-Exo effectively impeded AAA development in mouse models.
  • MSC-Exo suppressed CD74 levels, modulating macrophage polarization via the TSC2-mTOR-AKT pathway.

Conclusions:

  • MSC-Exo demonstrate therapeutic efficacy in AAA by promoting M2 macrophage polarization.
  • The therapeutic effect of MSC-Exo is macrophage-dependent.
  • MSC-Exo represent a promising therapeutic strategy for AAA targeting macrophage polarization.